The trilaminate vascular architecture provides biochemical regulation and mechanical integrity. Yet regulatory control can be regained after injury without recapitulating tertiary structure. Tissue-engineered (TE) endothelium controls repair even when placed in the perivascular space of injured vessels. It remains unclear from vascular repair studies whether endothelial implants recapitulate the vascular epithelial lining or expose injured tissues to endothelial cells (ECs) with unique healing potential because ECs line the vascular epithelium and the vasa vasorum. We examined this issue in a nonvascular tubular system, asking whether airway repair is controlled by bronchial epithelial cells (EPs) or by ECs of the perfusing bronchial vasculature. Localized bronchial denuding injury damaged epithelium, narrowed bronchial lumen, and led to mesenchymal cell hyperplasia, hypervascularity, and inflammatory cell infiltration. Peribronchial TE constructs embedded with EPs or ECs limited airway injury, although optimum repair was obtained when both cells were present in TE matrices. EC and EP expression of PGE 2, TGF␤1, TGF␤2, GM-CSF, IL-8, MCP-1, and soluble VCAM-1 and ICAM-1 was altered by matrix embedding, but expression was altered most significantly when both cells were present simultaneously. EPs may provide for functional control of organ injury and fibrous response, and ECs may provide for preservation of tissue perfusion and the epithelium in particular. Together the two cells optimize functional restoration and healing, suggesting that multiple cells of a tissue contribute to the differentiated biochemical function and repair of a tissue, but need not assume a fixed, ordered architectural relationship, as in intact tissues, to achieve these effects.
The trilaminate vascular architecture provides biochemical regulation and mechanical integrity. Yet regulatory control can be regained after injury without recapitulating tertiary structure. Tissue-engineered (TE) endothelium controls repair even when placed in the perivascular space of injured vessels. It remains unclear from vascular repair studies whether endothelial implants recapitulate the vascular epithelial lining or expose injured tissues to endothelial cells (ECs) with unique healing potential because ECs line the vascular epithelium and the vasa vasorum. We examined this issue in a nonvascular tubular system, asking whether airway repair is controlled by bronchial epithelial cells (EPs) or by ECs of the perfusing bronchial vasculature. Localized bronchial denuding injury damaged epithelium, narrowed bronchial lumen, and led to mesenchymal cell hyperplasia, hypervascularity, and inflammatory cell infiltration. Peribronchial TE constructs embedded with EPs or ECs limited airway injury, although optimum repair was obtained when both cells were present in TE matrices. EC and EP expression of PGE 2, TGF␤1, TGF␤2, GM-CSF, IL-8, MCP-1, and soluble VCAM-1 and ICAM-1 was altered by matrix embedding, but expression was altered most significantly when both cells were present simultaneously. EPs may provide for functional control of organ injury and fibrous response, and ECs may provide for preservation of tissue perfusion and the epithelium in particular. Together the two cells optimize functional restoration and healing, suggesting that multiple cells of a tissue contribute to the differentiated biochemical function and repair of a tissue, but need not assume a fixed, ordered architectural relationship, as in intact tissues, to achieve these effects.
tissue engineering ͉ airway disease ͉ vascular disease C ontrol of vascular homeostasis after injury can be regained without restoring normal and complex vascular architecture. Endothelial cells (ECs) embedded within a 3D denatured collagen matrix secrete antiproliferative, antithrombotic, and antiinflammatory agents that promote vascular repair even when such constructs are placed far from the lumen within the vascular adventitia. Luminal inflammation, occlusive thrombosis, and intimal hyperplasia can be controlled by allo-and xenogeneic matrix-embedded (ME) ECs in a manner indistinct from native endothelium and without eliciting a significant immune response (1) (2) (3) (4) (5) (6) (7) (8) . The challenge posed is whether endothelial implants recapitulate the endothelium lining as an epithelium or add to the regulation by perfusing vessels of the vasa vasorum, which are principally comprised of ECs. This question, however, cannot be elucidated in a blood vessel where ECs of vasa vasorum and vascular epithelium are one and the same. In all other physiological tubes, the ECs still comprise the perfusing microvasculature, but a more distinct cell serves as an epithelial lining. Structural similarities and differences between blood vessels and other tubular physiological structures provide an opportunity to investigate how ME cells mediate repair.
As with blood vessels, the airways, intestines, ureters, and fallopian tubes possess a trilaminate form that offers structural integrity and flow modulation, as well as profound regulation of local inflammation, thrombosis, hemostasis, proliferation, and remodeling (9) (10) (11) . In these structures, a loose fibrous adventitia is replete with coursing arterioles, venules, and neural forms; a middle muscularis layer provides control of luminal dimensions and tone; and a surface layer contains cells that biochemically regulate the wall response, sense flow, and luminal contents.
The airway epithelium, like the vascular endothelium, was once thought to be only a physical barrier between the inner tissues of the respiratory system and the external environment. It is now recognized that the epithelium regulates an array of airway functions, including control of lung fluid balance, attraction and activation of inflammatory cells, metabolism and clearance of inhaled agents, and regulation of airway smooth muscle function. As with the vascular endothelium, the airway epithelium exerts this control through the diverse array of compounds it can produce, such as growth factors, airwayconstricting peptides, chemokines, cytokines, gases, and lipid mediators (9, 12) . In airway disorders, such as asthma and chronic obstructive pulmonary disease (COPD), a functional imbalance is tightly associated with remodeling of airway structure. Remodeling can establish an abnormal microenvironment between the epithelium and underlying mesenchyme, finally resulting in a pathophysiological cycle of inflammatory injury and aberrant repair (13, 14) . These alterations in airway remodeling recapitulate features in the development of neointima formation, where endothelium injury initiates a repair response that can lead to luminal narrowing and diminished vessel function (15) .
In the present article, we used an in vivo airway injury model and cell culture models to understand whether injury and repair of the airway are mediated by the first-line sensor, the airway epithelium, or by the ECs of the perfusing vasculature. TE implants of the bronchial epithelium and endothelium promoted specific and synergistic repair of the airway through biochemical regulation of the airway microenvironment. Whereas epithelial cells (EPs) modulate local tissue composition and reaction, ECs preserve the epithelium and perfusing microvasculature; together, their relative impact was enhanced, suggesting both cell types are required for optimal airway repair. From these find-ings, it may be inferred that, in vascular injury, engineered EC implants recapitulate aspects of ECs from both the epithelium and perfusing microvasculature, whereas airways and other tubular organs likely require distinct EP and EC implants to achieve the same degree of repair. In all of these cases, healing does not require the reconstitution of architecture.
Results
Growth Kinetics of ME Cells. Normal human bronchial EPs and human aortic ECs were grown to confluence on tissue culture polystyrene (TCPS) and to growth arrest in denatured collagen matrices. The morphology of ECs (Fig. 1A) and EPs (Fig. 1B ) on TCPS were distinct; the former exhibit a tight cobblestone appearance, whereas the latter appear as smaller, cuboidal basal cells interspersed with larger, squamous mucous cells. Cell growth on denatured collagen-coated TCPS (DCCT) was identical to growth on TCPS alone. As on TCPS, the morphology of ME-ECs (Fig. 1 D and G) and ME-EPs ( Fig. 1 E and H) were distinct. ECs and EPs attained planar confluence on TCPS, but in less constrained forms in matrices. Embedded ECs retained a cobblestone appearance, and EPs appeared in their native cuboidal basal and squamous mucosal forms. Interestingly, from visual observation, cocultures of EPs and ECs on TCPS seemed to remain in isolated single-cell colonies separated by an extracellular matrix barrier, whereas the cell types were interspersed in the matrices (Fig. 1C) . To obtain similar growth kinetics over 28 days, 2 ϫ 10 5 EPs or 0.9 ϫ 10 5 ECs were initially seeded in the matrices (2.5 ϫ 1.0 ϫ 0.3 cm 3 ) [supporting information (SI) Fig. S1 ]. Cells' density peaked at 12-14 days and plateaued thereafter. Cell viability over a 28-day culture period, as assessed by trypan blue exclusion, averaged 91.9 Ϯ 0.47% for embedded EPs, 92.6 Ϯ 0.33% for ECs, and 91.2 Ϯ 0.19% with both cells present.
Biosecretory Activity of ME Cells. The EP and EC production of biosecretory factors involved in airway injury and repair (9, 12) was similarly dependent on matrix embedding and the presence of complementary cell type. In comparison with TCPS or DCCT cell seeding, prostaglandin E 2 (PGE 2 ) and TGF␤1 were elevated in ME-EPs and lower for ME-ECs. GM-CSF was increased in both embedded EPs and ECs, and TGF␤2 was reduced in ME-EC. In contrast, when EPs and ECs resided together in the matrices, all molecules examined were down-regulated with or without TNF␣ stimulation ( Fig. 2A and Fig. S2 ). This effect extended to the expression of proinflammatory molecules. IL-8 release was significantly lower in all ME cells compared with growth on TCPS and DCCT ( Fig. 2B and Fig. S3 ). Monocyte chemoattractant protein (MCP)-1 production was reduced significantly in embedded ECs and EPs/ECs, compared with tissue culture plate conditions. EPs expressed relatively low levels of MCP-1 compared with ECs and EPs/ECs for all conditions. The soluble form of ICAM-1 (sICAM-1) was significantly reduced in embedded ECs and EPs/ECs and significantly increased in ME-EPs, compared with tissue culture plate conditions; however, EP production of sICAM-1 was relatively low compared with ECs and EPs/ECs. Embedded EC and EP/EC release of the soluble form of VCAM-1 (sVCAM-1) was significantly decreased compared with tissue culture plate conditions, whereas EP release was significantly higher. Similar to EP expression of sICAM-1, EP expression of sVCAM-1 was relatively low compared with ECs and EPs/ECs for all conditions. EP and EC Implants Differentially Regulate Airway Repair. Twentynine rabbits underwent controlled airway injury and randomly received no further therapy, acellular matrices, or matrices with ECs or EPs alone or together. Brush injury induced reproducible tracheal epithelial denudation over 30% of the surface area and with significant thinning elsewhere. Such injury resulted in luminal narrowing, mesenchyme cell hyperplasia, collagen deposition, hypervascularity, and infiltration of inflammatory cells (Fig. 3) . Tissue effects were mirrored on a cellular level. Extensive cell damage and airway remodeling were noted in the absence of further intervention ( Fig. 3 C and D) , compared with control uninjured airways ( Fig. 3 A and B) , and unaffected by matrices alone ( Fig. 3 E and F) . ME cells enhanced repair in a distinct manner when alone and synergistically when cultured together ( Fig. 3 
G-L).
Luminal obstruction and airway remodeling were controlled by ME-EP, alone and with ME-ECs, and, to a lesser extent, isolated ME-ECs (Figs. 4 and 5 ). The area of the airway lumen was reduced with injury (Ϫ17.9 Ϯ 4.2%, compared with uninjured control segments). Whereas acellular matrices had no effect on this injury, the lumen was preserved in major part by ME-EC, with a 62.5 Ϯ 6.5% reduction in luminal occlusion, and dilated to a degree by embedded EPs (3.0 Ϯ 2.3%) and even greater with ME of both cells together (8.9 Ϯ 4.0%) (Fig. 5A ). Epithelial area was reduced 22.0 Ϯ 5.9% by injury and was unaffected by acellular implants. Epithelial area was best preserved in tracheas wrapped with embedded ECs alone (110.5 Ϯ 6.1%) or with EPs (120.1 Ϯ 9.3%) but to lesser extent with EPs (105.6 Ϯ 10.5% (Fig. 5B ). Epithelial surface area was similarly greatest in the combined cell group at 80.9 ϩ 3.9%, but in no specimen was complete epithelial recovery observed. The values for total area reflect the complex epithelial structure that, unlike the monolayer of the vascular endothelium, has a defined thickness. There was no difference in cartilage area among all of the conditions (Fig. 5C ). Mesenchymal hyperplasia was evident after injury as an 18.9 Ϯ 8.0% increase in thickness and was made, if anything, subtly worse with empty matrices (124.3 Ϯ 7.2%). EC implants had no affect on the mesenchyme, and EP matrices reduced thickening by 40.0 Ϯ 1.8% and virtually eliminated hyperplasia altogether with implants containing ECs and EPs (Fig. 4D ). Injured airways were hypervascular with 29.9 Ϯ 18.5% greater vessel density and marginally worse when wrapped with acellular matrices, 32.9 Ϯ 14.4%. Injured airways were marginally better with embedded ECs, significantly reduced by EPs (64.9 Ϯ 4.4%), and relatively normal in matrices with both cells (Fig. 5E ). Tissue injury as a percentage of mesenchyme area was 2.4-fold reduced in tracheas wrapped with EPs and ECs (14.5 Ϯ 1.4%), compared with no implants, empty implants, or implants with ECs ( Fig. 5F ). Embedded EPs had a midrange effect with a 24.9 Ϯ 0.75% reduction in injury.
As the matrix implants degrade, they allow for moderate and controlled inflammatory cell infiltration. This finding was evident in all sections and was no different in implants with and without cells. Similarly, tissue inflammation was identical with or without implanted matrices. The extent of fibrosis and necrosis was less in tracheas wrapped with matrices containing EPs alone or with ECs. The incidence of stridor in the rabbits was recorded 9 days after brush injury. Only one of six (17%) rabbits that did not have implants exhibited signs of stridor, whereas stridor was presented in five of seven (71%) rabbits treated with acellular devices. Interestingly, the incidence of stridor in rabbits treated with ME-ECs was only two of seven (29%), whereas no signs of stridor were observed in the five rabbits treated with ME-EPs or the four rabbits treated with dual-cell implants.
Fibroblast Growth Inhibited by ME Cells. Fibroblasts are an essential supporting cell of the airway and the mesenchymal hyperplastic lesion. Normal human lung fibroblast (NHLF) proliferation was maximally reduced when cocultured with matrices containing EPs alone, modestly reduced by embedded EPs and ECs, and unaffected by ME-EC cocultures. The EP effect depended on prostaglandin production. Then, 5 M indomethacin aborted fibroblast growth inhibition ( Fig. 6 A and B) , and production of PGE 2 , a potent inhibitor of fibroblast proliferation (16) (17) (18) , inversely correlated with NHLF growth in our coculture system (R 2 ϭ 0.95) (Fig. 6C) . PGE 2 levels were highest (2,231.7 Ϯ 81.1 pg/ml) in NHLF cocultured with ME-EPs, rising Ͼ50-fold above that seen with fibroblasts alone (40.2 Ϯ 2.0 pg/ml). In contrast, ME-ECs reduced PGE 2 levels 2-fold (20.4 Ϯ 1.8 pg/ml) when alone and limited the EP increase 4-fold (549.2 Ϯ 60.7 pg/ml). Indomethacin significantly diminished PGE 2 production in both NHLF cultures with embedded EPs or EPs/ECs (Fig. 6D ).
Tube Formation Inhibited by ME Cells. The effect of ME cells on angiogenesis in vitro was examined by tube formation of human umbilical vein endothelial cells (HUVECs) cultured with conditioned medium. This process involved migration, invasion, and differentiation of HUVECs in the formation of the tubular network ( Fig. S4A) (19, 20) . Tube length and branch point numbers were highest with embedded ECs and lowest with embedded EPs, and together the cells matched acellular controls (Fig. S4 B-D) . Tube formation correlated with FGF-2 production by embedded cells (R 2 ϭ 0.95) (Fig. S4 E and F) .
Discussion
Unlike blood vessels in which the ECs serve as both the central element of the epithelium and vasa vasorum, the airway epithelium is composed of highly differentiated cells that are quite distinct from the ECs that line the bronchial vasorum. This cellular distinction in the airway allowed for an investigation of the differential control these two cell systems may provide in mediating tissue repair. We found that TE implants of the bronchial epithelium and endothelium promoted specific and synergistic repair of the airway after controlled, quantifiable injury through unique biochemical regulation of the airway microenvironment. It appears that, although epithelial cells limit tissue injury and mesenchymal hyperplasia, ECs promote preservation of the epithelium and perfusion of the injured tissue. Moreover, each effect is augmented in the presence of its complementary cell type, and overall repair is optimal when both cells are presented to the injured airway.
EPs and ECs display identical growth kinetics when embedded in denatured collagen matrices (Fig. S1) . Matrix embedding enabled cell growth with less strained conformational molding to substratum, without imposing planar restraint, and retention of distinct morphology and secretory ability even without complete contiguity. In contrast to the morphology observed on TCPS and DCCT, coembedded ECs and EPs are interspersed with no apparent interceding physical barrier (Fig. 1) .
The functional impact of these cellular differences was studied in a model of controlled tracheal injury. Embedded EPs and/or ECs were implanted in the tracheal adventitial space external to the site of denuding bronchial epithelial injury. Localized brush injury to rabbit tracheal epithelium produced stridor and pathological characteristics that often accompany airway diseases such as asthma and COPD. These changes include luminal narrowing, epithelial damage, mesenchymal cell hyperplasia, and hypervascularity (Fig. 3 A-F) (9, 12, (21) (22) (23) . Peribronchial cuffing with implanted matrices may exacerbate injury as in other wrapped organs (24) . Airflow was sufficiently restricted by combined brush denudation from within and acellular matrices from without to increase stridor Ͼ4-fold compared with injury alone. The response to our airway injury is reminiscent of inflammatory and proliferative reactions to vascular endothelial denudation that result in intimal hyperplasia, luminal narrowing, and diminished vessel function (15) . As in blood vessels in which ME-ECs restored function well before restoring architectural integrity, embedded EPs or EPs/ECs preserved airway health and enhanced repair before restoring airway structure. Biochemical production, morphological effects, and functional benefit were all optimized by dual cell implants and without the need to completely rebuild the injured airway.
Remodeling in airway diseases includes major structural and functional changes to the mesenchyme, along with angiogenesis and microvascular remodeling. Larger, more abundant, and dysfunctional blood vessels are formed with uncontrolled permeability, leukocyte adhesion, and local inflammation (23, (25) (26) (27) . The impact of ME-EP extended into these domains as well, restricting the hypervascular mesenchymal response to injury, but to such an extent that this layer was perhaps underperfused (65% of control). Tracheobronchial segments treated with ME-ECs were hyperplastic (121% of control) and hypervascular (119% of control), no different from untreated tissue. However, together, ECs and EPs achieved the ideal set point, maximizing all indices of repair by enhancing luminal and epithelium areas, inhibiting mesenchymal hyperplasia and hypervascularity, and significantly reducing the extent of tissue injury (Figs. 4 and 5) .
A powerful bidirectional communication exists between the epithelium and the subepithelial mesenchyme. Repairing epithelium produces factors that directly influence subepithelial fibroblast migration, remodeling, and differentiation into myofibroblasts. In turn, these underlying cells release growth factors that promote autocrine proliferation and paracrine effects on blood vessels, smooth muscle, and the epithelium (9, 21). EPs and ECs cultured separately or together secrete different patterns of airway-repair and injury-specific molecules on TCPS or DCCT, and these cellular secretion levels are modulated significantly further when these cells are matrix embedded (Fig. 2 and Figs. S2 and S3) (9, 12, 21) . All molecules studied were downregulated in coembedded EPs and ECs with or without TNF␣ stimulation. Whereas ME-EP express higher levels of PGE 2 , GM-CSF, and TGF␤1, ME-ECs secrete lower levels of PGE 2 , TGF␤1, and TGF␤2 compared with cells on TCPS and DCCT. The diverse expression patterns among EPs, ECs, and EPs/ECs grown on TCPS, DCCT, or in matrices may arise from complex cellular, biochemical, and substrate-specific interactions regulating cellular secretion.
The secretion of mediators of vascular and bronchial biology may attain different local levels and act differently when both ECs and EPs are present together rather than alone. For example, PGE 2 is a potent bronchodilator that stabilizes extracellular matrix in the airway (16, 28) and inhibits fibroblast proliferation (16, 18 ). Yet, this same molecule also induces vascular permeability and edema (29) . Therefore, the influence of PGE 2 on bronchial injury might well be appreciated differentially by EPs or ECs alone or the two cells together. Indeed, ME-EP inhibition of NHLF growth correlated with the production of PGE 2 , and both were reversed by the cyclooxygenase 1 and 2 inhibitor indomethacin. FGF-2 has similar potentially competing organ-specific functions. This growth factor is a potent vascular endothelial mitogen and angiogenic factor (25) but also stimulates bronchial smooth muscle cell proliferation and airway inflammation (30) . Therefore, it is fascinating that, although ME-EPs produce the lowest amount of FGF-2 and reduce tube formation in vitro and mesenchymal vascularization in vivo, the reverse is true for ECs. ME-ECs modestly enhance tube formation and branching in vitro in concert with elevated FGF-2 ( Fig. S4E) and stimulate neovascularization to a small degree after airway injury. The most balanced effect is seen when the two cells are together. Vascular density is restored to control states in vivo and branching and tube formation are restored to control levels in vitro.
Local inflammation seems dominated by endothelial biology, and endothelial immunogenicity and interaction with immune cells are governed by cell matrix interconnections. The immunological response, in previous studies, to allogeneic and even xenogeneic ECs was muted and even reduced the minimal inflammatory cell infiltration that accompanies the controlled pace of matrix degradation (4, 6, 8) . ME-ECs express decreased levels of MHC class II, costimulatory, chemokine, and adhesion molecules compared with planar ECs (1-4, 31) . We now show significantly reduced expression of IL-8, MCP-1, sICAM-1, and sVCAM-1 by embedding of ECs alone or with EPs. ME-EPs produce lower levels of IL-8 compared with TCPS and DCCT levels but more sICAM-1 and sVCAM-1; all of these levels are relatively low compared with ECs alone or EPs and ECs together. We have not previously reported embedding of a cell type other than ECs altering expression levels of proinflammatory molecules. These results, along with our previous findings, raise questions as to whether altered molecule expression and reduced cell immunogenicity of embedded cells arise from cell attachment alone or only when combined with a specific supporting substratum. The peribronchial infiltration of inflammatory cells in xenogeneic-embedded EC and EP implants was moderate and indistinguishable from acellular matrices.
Tissue engineering provides a platform to differentiate the distinct effects of different cells alone and together on local tissue repair. Two of the major cells resident in the airway, the ECs and EPs, offer synergistic healing linked to their unique biochemical function. The EPs that serve as local biosensors and highly differentiated secretory cells have the greatest range of effect, whereas the ECs, which comprise nourishing vessels, aid in preservation of the epithelium and perfusing microvasculature. It is becoming evident that the EPs may well provide for functional control of organ injury and fibrous response, and ECs may well provide for preservation of the tissue perfusion, and the epithelium in particular. Together, the two cells optimize functional restoration and healing. In vascular injury, embedded ECs may enable vascular repair through simultaneous recapitulation of two regulatory units, the vascular endothelium as an epithelium and ECs in arteries of the vasa vasorum. The airway and other tubular organs, however, likely require the intact function of their distinct epithelial cells as well as ECs to achieve the same degree of repair, and in none of these cases is recapitulation of the final ordered architecture an absolute necessity for healing.
Methods
Cell Culture and Cell Engraftment. EPs were grown in bronchial epithelial growth medium (BEGM), ECs and HUVECs were grown in endothelial growth medium-2 (EGM-2) supplemented with 10% FBS, and NHLFs were grown in fibroblast growth medium supplemented with 5% FBS. When EPs and ECs were cocultured, a 1:1 mixture of BEGM:EGM-2 was used. EPs and ECs also were grown together or separately on Gelfoam (Amersham Pharmacia/ Upjohn), a denatured collagen matrix.
Animals and Surgical Procedure.
A modified version of a rabbit airway injury model (32) recapitulated acute and chronic changes of airway structure and function. A long midline incision was made exposing the trachea. A 2-mm nylon brush inserted through an endotracheal tube was advanced and withdrawn across a defined area of the trachea 10 times, inducing a localized and
served as controls. Localized nylon brush injury of rabbit tracheal epithelium was confirmed with trypan blue dye transport (Fig. 4 A and B) .
Tissue Processing and Analysis. After removal, the tracheas were fixed in 10% formalin and sectioned into 3-mm-long segments. Five-micrometer sections were obtained from the proximal, middle, and distal segments and stained with H&E and verHoeff's elastin stain. The degree of airway injury was determined by morphometric analysis (Fig. 4 C and D) .
Biosecretory Characterization. The biosecretory function of ECs and EPs in denatured collagen matrices, TCPS, and DCCT, were compared. TNF␣ was used as a stimulant given its inflammatory and cytotoxic involvement in a broad range of pulmonary diseases (33) . After 24 h, the medium was collected and analyzed by using commercially available ELISA kits.
Fibroblast Cocultures. NHLFs were seeded at 5 ϫ 10 4 cells per well and grown for 48 h on six-well transwell plates (Costar). Fresh medium (5 ml per well of BEGM:EGM-2, 1:1) was then added with or without 5 M indomethacin (Sigma), and 24-mm inserts (0.4-m membrane) with matrices (engrafted with ECs, EPs, or EPs/ECs) were placed on top of the NHLFs. After an additional 48 h, NHLFs were trypsinized, and the total cell number for each well was determined with a cell counter (Coulter). Medium was collected and analyzed by using commercially available ELISA kits.
In Vitro Tube-Formation Assay. A CAS HT tube formation kit (Trevigen) was used. HUVECs were plated at a density of 2 ϫ 10 4 cells per well and incubated at 37°C for 8 h with either BEGM:EGM-2 (1:1) medium unconditioned (incubated at 37°C without cells for 48 h) or conditioned for 48 h from matrices engrafted with ECs, EPs, or EPs/ECs. Images from four microscopic fields per well were analyzed by using Adobe Photoshop CS3 software.
Data and Statistical Analysis. All data are expressed as means Ϯ SE. All statistical analysis was performed by using Statistica 6.0 software. Data between two groups were analyzed by Student's t test. Data among more than two groups were evaluated by ANOVA, followed by Fisher's least significant difference post hoc test to assess intergroup significance. A value of P Ͻ 0.05 was considered significant. , and all growth medium were obtained from Lonza. Bronchial epithelial growth medium (BEGM) was supplemented with 0.4% bovine pituitary extract, 0.1% hydrocortisone, 0.1% human EGF (hEGF), 0.1% epinephrine, 0.1% transferring, 0.1% insulin, 0.1% retinoic acid, 0.1% triiodothyronine, 0.1% gentamicin, amphotericin-B (GA-1000), and 20 units/ml penicillinstreptomycin. EGM-2 was supplemented with 10% FBS, 0.4% hEGF, 0.04% hydrocortisone, 0.1% R3-insulin-like growth factor-1, 0.1% vascular EGF, 0.1% human FGF-B (hFGF-B), 0.1% ascorbic acid, 0.1% Heparin 0.1% GA-1000, and 20 units/ml penicillin-streptomycin. Also, fibroblast growth medium (FGM) was supplemented with 5% FBS, 0.1% hFGFr-B, 0.1% insulin, 0.1% GA-1000, and 20 units/ml penicillin-streptomycin.
Additional
Cells were grown on uncoated polystyrene tissue culture polystyrene (TCPS) and denatured collagen-coated TCPS (DCCT; Becton-Dickinson; 10 mg/ml gelatin; Sigma). Two human donors for both EPs and ECs were used throughout these studies, but were not pooled for specific experiments. Levels of PGE 2 (Cayman Chemical), TGF-␤2 (R&D Systems), GM-CSF, and TGF-␤1 (Invitrogen) were used as internal controls between the donors for each cell type. Measurements were made by using commercially available ELISA kits and were found to be not significantly different between the two donors for both EPs and ECs (data not shown). Cells were used between passages 2 and 7 and cultured at 5% CO 2 at 37°C.
Depending on the specific experiment, denatured collagen matrix sheets were cut into blocks measuring 1.5 ϫ 1.0 ϫ 0.3 to 3.5 ϫ 1.0 ϫ 0.3 cm 3 . Matrices were then hydrated in BEGM and/or EGM-2 for at least 30 min depending on the cell type(s) to be seeded. Immediately before seeding, matrices were placed horizontal on TCPS with no liquid. ECs (0.9 ϫ 10 5 ) and/or EPs (2 ϫ 10 5 ) were then concentrated to 100 l, added to the surface of the matrices, and incubated for 3 h (5% CO 2 at 37°C). Matrices were then transferred to free-standing 15-ml polypropylene tubes containing 10 ml of EGM-2 and/or BEGM. Under standard culture conditions, cells were allowed to invade the blocks, lining the interstices of the matrices for up to 2 weeks. Cell viability was determined by trypan blue exclusion.
Animals and Surgical Procedure. This study conformed to the guidelines specified in the National Institutes of Health's Guide for Care and Use of Laboratory Animals and was approved by the Harvard Medical Area Standing Committee on Animals. At day 0, female New Zealand White rabbits (3.5-4.7 kg and 6 months to 1 year old) were sedated with 1 mg/kg acepromazine i.m., 0.01 mg/kg glycopyrrolate i.m., and 0.2 mg/kg butorphanol i.m. Induction was performed by using 0.25 mg/kg medetomidine s.c., followed by a general anesthetic of isoflorane (1-2%) and oxygen on a pediatric nonrebreathing anesthetic system. The rabbits were started on isoflurane and oxygen as its anesthetic during the surgical procedure. Before intubation, a 2% cetacaine spray was used to prevent larygnospasm. The animals were placed in the supine position on a heated operating table, and heart rate and PO 2 were monitored throughout the procedure. After airway epithelial injury and matrix implantation, the midline incisions were sutured closed, and the animals were observed in separate cages during recovery. The rabbits were observed daily for respiratory distress, stridor, general health, and activity. At any sign of airway obstruction, the rabbit was killed. At day 9 after injury, the presence or lack of respiratory stridor was recorded. The rabbits were then killed, and samples were removed for histological and morphological examination.
Tissue Processing and Analysis. Multiple segments proximal to the injury, at the injury, and distal to the injury were paraffinembedded. Photomicrographs were taken with a DC-70 digital camera (Olympus). The lumen (L), epithelium (E), mesenchyme (M), mesenchyme injury (I), cartilage (C), and vascular (V) areas were measured in Adobe Photoshop CS3 software by an observer blinded to the treatment groups. For each trachea, all area measurements in the injured tracheal segments were represented as percent control by using the measurements of the uninjured tracheal segments proximal and distal to the injury as internal controls. The extent of mesenchyme injury was based on the combined areas of inflammation, fibrosis, and necrosis with the area being normalized for the size of the entire mesenchyme area.
Biosecretory Characterization. ECs and EPs were grown to confluence in all conditions. The same fresh medium (BEG-M:EGM-2, 1:1) was then added with or without TNF-␣ (10 ng/ml; Sigma) for all conditions. Cells were trypsinized from TCPS and DCCT and counted with a cell counter (Coulter). Cells in matrices were detached by collagenase type I (1 mg/ml; Worthington) digestion and counted using a hemocytometer. Release of TGF-␤2 (R&D Systems), PGE 2 (Cayman Chemical), sICAM-1, sVCAM-1, IL-8, GM-CSF, MCP-1, and TGF-␤1 (Invitrogen) were measured by using commercially available ELISA kits according to the manufacturers' instructions. Fresh medium was incubated without cells for 24 h, and a baseline level for each soluble factor was measured at the same time as medium with cells. The baseline levels were then subtracted from the experimental raw data to obtain the cellular expression of each soluble factor. The results for each soluble factor were then normalized by cell number and expressed in either picograms or nanograms per 10 5 cells.
In Vitro Tube Formation Assay. Reduced growth factor basement membrane extract purified from an Engelbreth-Holm-Swarm tumor was pipetted into wells of a 48-well plate (100 l/well) and incubated at 37°C for 1 h to allow the extract to solidify. Eight hours after seeding, images of tube formation were taken at ϫ40 on an inverted microscope (Nikon Diaphot) and camera (Nikon D50). The branch points of the formed tubes were counted, and the length of the tube network was measured for each image. The total number of branch points and total length of the network from the four images per well were calculated. Medium from each coculture was collected and analyzed. FGF-2 (Invitrogen) levels were measured by using a commercially available ELISA kit according to the manufacturer's instructions.
Scanning EM. ECs, EPs, and EPs/ECs were grown in matrices for 12 days, and then scanning EMs were obtained for each cell type. In preparation for image capture, the ME cells were washed once in warm PBS and fixed overnight at 4°C with 3% glutaraldehyde. The matrices were then washed twice with PBS for 10 min. A 2-mm biopsy punch was used to cut cores from the middle of the matrices. The cores were washed four times with ultrapure water for 5 min. Cores were then stained for 30 min with a 0.5% uranyl acetate solution, followed by four washes with ultrapure water for 5 min. Individual cores were placed in Quantomix TM QX-102 capsules. Sealed capsules were placed on the specimen stage to be viewed in the wet state with an S4300 SE-N (Hitachi) variable pressure scanning electron microscope equipped with a Schottky emitter. Imaging was performed by using a backscatter detector with emission energy of 15 kV and emission current of 90-100 mA at a working distance of 9.8-9.9 mm. Fig. S1 . EPs (2 ϫ 10 5 ), ECs (9 ϫ 10 4 ), and EPs/ECs (2 ϫ 10 5 and 9 ϫ 10 4 ) exhibit identical growth kinetics when embedded in denatured collagen matrices (n ϭ 3). Cells reached peaked density (mean Ϯ SE) at 12-14 days. To obtain similar growth kinetics over 28 days, cells were seeded in matrices (2.5 ϫ 1.0 ϫ 0.3 cm 3 ) with initial seedings of 2 ϫ 10 5 EPs or 0.9 ϫ 10 5 ECs. Cells reached a peaked density between 12-14 days. Thereafter, cell numbers remained fairly constant between days 15 and 28. Cell viability, by trypan blue exclusion, averaged 91.9 Ϯ 0.47% for ME-EP, 92.6 Ϯ 0.33% for ME-EC, and 91.2 Ϯ 0.19% for ME-EP/ECs over a 28-day culture period. Fig. 2 A with protein secretion levels of PGE2, GM-CSF, TGF-␤1, and TGF-␤2 from EPs, ECs, and EPs/ECs in TCPS, DCCT, and ME with or without TNF-␣ stimulation (10 ng/ml) for 24 h. Secretion levels were substratum and cell-specific (mean Ϯ SE, n ϭ 5-6). * , P Ͻ 0.05; ** , P Ͻ 0.001 vs. unstimulated; †, P Ͻ 0.01 vs. TCPS and DCCT unstimulated for the same cell type; ‡, P Ͻ 0.001 vs. TCPS:TNF-␣ and DCCT:TNF-␣ for the same cell type. * , P Ͻ 0.01 vs. control; †, P Ͻ 0.05; † †, P Ͻ 0.001 vs. compared condition. (E and F) Graphs depicting strong correlation between FGF-2 levels and total length of tube network (E) and total number of branch points per well (F).
Fig. S2. Expansion of

